Once-weekly insulin icodec: pharmacokinetic and pharmacodynamic properties in type 1 diabetes

被引:0
|
作者
Hoevelmann, U. [1 ]
Engberg, S. [2 ]
Heise, T. [1 ]
Kristensen, N. R. [2 ]
Norgreen, L. [3 ]
Ribel-Madsen, R. [2 ]
Zijlstra, E. [1 ]
Haahr, H. [2 ]
机构
[1] Profil, Neuss, Germany
[2] Novo Nordisk, Soborg, Denmark
[3] Novo Nordisk, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
779
引用
下载
收藏
页码:S399 / S400
页数:2
相关论文
共 50 条
  • [21] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Suzuki, Yuya
    Zhao, Tianchen
    Tsubokura, Masaharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08):
  • [22] Advances in Diabetes Treatment - Once-Weekly Insulin
    Gottlieb, Peter A.
    Michels, Aaron W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2171 - 2172
  • [23] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
    Rosenstock, Julio
    Bajaj, Harpreet S.
    Janez, Andrej
    Silver, Robert
    Begtrup, Kamilla
    Hansen, Melissa V.
    Jia, Ting
    Goldenberg, Ronald
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2107 - 2116
  • [24] Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes The ONWARDS 3 Randomized Clinical Trial
    Lingvay, Ildiko
    Asong, Marisse
    Desouza, Cyrus
    Gourdy, Pierre
    Kar, Soumitra
    Vianna, Andre
    Vilsboll, Tina
    Vinther, Siri
    Mu, Yiming
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (03): : 228 - 237
  • [25] Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naive Type 2 Diabetes (ONWARDS 3)
    Lingvay, Ildiko
    Asong, Marisse
    Desouza, Cyrus
    Gourdy, Pierre
    Kar, Soumitra
    Vianna, Andre G.
    Vilsboll, Tina
    Vinther, Siri M.
    Mu, Yiming
    DIABETES, 2023, 72
  • [26] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes by Ethnicity and Race-ONWARDS 1-5
    Lingvay, Ildiko
    Bangsgaard, Katrine O.
    Desouza, Cyrus
    Marques, Mariana Fragao
    Navarria, Andrea, Sr.
    Vianna, Andre G.
    DIABETES, 2024, 73
  • [27] Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)
    Polonsky, W.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Goldenberg, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S400 - S400
  • [28] Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials
    Abuelazm, Mohamed
    Ibrahim, Ahmed A.
    Khlidj, Yehya
    Badr, Amr
    Amin, Ahmed Mazen
    Elzeftawy, Mohamad A.
    Gowaily, Ibrahim
    Elsaeidy, Ahmed Saad
    Abdelazeem, Basel
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (02)
  • [29] Better glycaemic control with once-weekly insulin icodec versus once-daily insulin degludec in adults with insulin-naive type 2 diabetes (ONWARDS 3)
    Lingvay, I.
    Asong, M.
    Desouza, C.
    Gourdy, P.
    Kar, S.
    Vianna, A.
    Vilsboll, T.
    Vinther, S.
    Mu, Y.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S7
  • [30] Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
    Kjeldsen, Thomas B.
    Hubalek, Frantisek
    Hjorringgaard, Claudia U.
    Tagmose, Tina M.
    Nishimura, Erica
    Stidsen, Carsten E.
    Porsgaard, Trine
    Fledelius, Christian
    Refsgaard, Hanne H. F.
    Gram-Nielsen, Sanne
    Naver, Helle
    Pridal, Lone
    Hoeg-Jensen, Thomas
    Jeppesen, Claus Bekker
    Manfe, Valentina
    Ludvigsen, Svend
    Lautrup-Larsen, Inger
    Madsen, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 8942 - 8950